Carson Allaria Wealth Management, Ltd. Gilead Sciences, Inc. Transaction History
Carson Allaria Wealth Management, Ltd.
- $169 Million
- Q4 2024
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 120 shares of GILD stock, worth $13,414. This represents 0.01% of its overall portfolio holdings.
Number of Shares
120
Previous 120
-0.0%
Holding current value
$13,414
Previous $10,000
10.0%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
2,101Shares Held
987MCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.02 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.75 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.48 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $140B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...